US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 1.1009
  • -0.0491-4.27%
Close Nov 26 16:00 ET
  • 1.1003
  • -0.0006-0.05%
Post 16:50 ET
2.25MMarket Cap-82P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
Net income from continuing operations
-84.57%-3.17M
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
Change In working capital
-45.30%-266.76K
353.00%683.55K
-134.28%-157.43K
662.38%863.68K
327.75%858.2K
50.60%-183.59K
-142.92%-270.18K
1,428.23%459.25K
-153.04%-153.58K
-244.80%-376.82K
-Change in prepaid assets
11.17%-370.9K
7.63%273.38K
-46.00%94.42K
33.42%162.7K
-26.10%151.4K
18.05%-417.55K
-44.12%254K
726.18%174.85K
116.26%121.94K
-20.38%204.87K
-Change in payables and accrued expense
-55.49%104.13K
178.25%410.17K
-188.55%-251.85K
354.43%700.98K
221.51%706.8K
69.71%233.96K
-399.58%-524.17K
4,374.78%284.4K
-126.50%-275.52K
-20,034.51%-581.69K
Cash from discontinued investing activities
Operating cash flow
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
13,131.36%4.62M
54.71%2.34M
0
77.84%7.61M
1.95M
-17,809.50%-35.42K
-64.64%1.51M
4.18M
-73.21%4.28M
0
Net common stock issuance
12,933.26%4.55M
59.34%2.41M
--0
77.85%7.61M
--1.95M
---35.42K
-64.64%1.51M
--4.17M
-72.21%4.28M
--0
Proceeds from stock option exercised by employees
--168
--0
--0
-34.84%187
--0
--0
-60.92%34
--153
--287
--0
Cash from discontinued financing activities
Financing cash flow
13,131.36%4.62M
54.71%2.34M
--0
77.84%7.61M
--1.95M
-17,809.50%-35.42K
-64.64%1.51M
--4.18M
-73.21%4.28M
--0
Net cash flow
Beginning cash position
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
-42.20%6.24M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
1,935.97%10.8M
-35.99%8.07M
Current changes in cash
166.22%1.2M
165.02%213.42K
-207.09%-2.7M
126.26%1.2M
144.19%806.65K
29.44%-1.81M
-113.47%-328.23K
196.84%2.53M
-144.38%-4.56M
-1.16%-1.83M
End cash Position
-7.35%6.14M
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
Free cash flow
-92.98%-3.42M
-15.52%-2.13M
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -92.98%-3.42M-15.52%-2.13M-63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M
Net income from continuing operations -84.57%-3.17M-66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M
Change In working capital -45.30%-266.76K353.00%683.55K-134.28%-157.43K662.38%863.68K327.75%858.2K50.60%-183.59K-142.92%-270.18K1,428.23%459.25K-153.04%-153.58K-244.80%-376.82K
-Change in prepaid assets 11.17%-370.9K7.63%273.38K-46.00%94.42K33.42%162.7K-26.10%151.4K18.05%-417.55K-44.12%254K726.18%174.85K116.26%121.94K-20.38%204.87K
-Change in payables and accrued expense -55.49%104.13K178.25%410.17K-188.55%-251.85K354.43%700.98K221.51%706.8K69.71%233.96K-399.58%-524.17K4,374.78%284.4K-126.50%-275.52K-20,034.51%-581.69K
Cash from discontinued investing activities
Operating cash flow -92.98%-3.42M-15.52%-2.13M-63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 13,131.36%4.62M54.71%2.34M077.84%7.61M1.95M-17,809.50%-35.42K-64.64%1.51M4.18M-73.21%4.28M0
Net common stock issuance 12,933.26%4.55M59.34%2.41M--077.85%7.61M--1.95M---35.42K-64.64%1.51M--4.17M-72.21%4.28M--0
Proceeds from stock option exercised by employees --168--0--0-34.84%187--0--0-60.92%34--153--287--0
Cash from discontinued financing activities
Financing cash flow 13,131.36%4.62M54.71%2.34M--077.84%7.61M--1.95M-17,809.50%-35.42K-64.64%1.51M--4.18M-73.21%4.28M--0
Net cash flow
Beginning cash position -41.37%4.95M-46.00%4.73M19.18%7.44M-42.20%6.24M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M1,935.97%10.8M-35.99%8.07M
Current changes in cash 166.22%1.2M165.02%213.42K-207.09%-2.7M126.26%1.2M144.19%806.65K29.44%-1.81M-113.47%-328.23K196.84%2.53M-144.38%-4.56M-1.16%-1.83M
End cash Position -7.35%6.14M-41.37%4.95M-46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M
Free cash flow -92.98%-3.42M-15.52%-2.13M-63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data